MM-specific universal CAR T
/ SZGIMI
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
August 23, 2023
Universal CAR-T Cells Targeting Multiple Myeloma
(clinicaltrials.gov)
- P1 | N=20 | Recruiting | Sponsor: Shenzhen Geno-Immune Medical Institute
CAR T-Cell Therapy • New P1 trial • Hematological Malignancies • Multiple Myeloma • Oncology
1 to 1
Of
1
Go to page
1